Aspect Biosystems
PrivateLast Round
Grant
Apr 2, 2026
Total Funding Raised
$249.28M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aspect Biosystems is a biotechnology company that develops a full-stack tissue therapeutic platform using proprietary AI-powered bioprinting technology to create implantable bioprinted tissue therapeutics for metabolic and endocrine diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, 3D Printing, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aspect Biosystems Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aspect Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2026 | ||||
| Series B | Jan 8, 2025 | ||||
| Grant | Jul 10, 2024 | ||||
| Grant | Mar 20, 2023 | ||||
| Series A | Jan 9, 2020 | ||||
Grant | Nov 15, 2018 |
Key People
Founding team and executive leadership
Aspect Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InBC Investment Corp. | Series B |
| Genome British Columbia | VC Round |
| Dimension | Series B |
| Government of British Columbia | Grant |
| Government of Canada | Grant |
| JDRF | Series B |
| Endure Capital | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
$57M grant funding secured.
- Jan 23, 2026
Will develop therapies based on stem cell-derived islets.
Aspect Biosystems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aspect Biosystems's valuation, stock price, and market status.